COVID-19: Vaccines and Therapeutics
A new video from AHA and the Children’s Hospital Association is reminding the public how vaccines and boosters are safe, effective means for preventing pediatric illness from COVID-19, the flu and RSV.
In a new public service announcement, leaders of the AHA, American Medical Association and American Nurses Association encourage the public to get vaccinated and boosted against COVID-19 when eligible to protect themselves, their families and communities from serious disease and death.
When the omicron BA.4/BA.5 variants were circulating, Americans who received an updated COVID-19 vaccine were 14 times less likely to die than those who received no vaccine and five times less likely to die than those who received the original monovalent vaccine, according a study released today by…
Together, the American Hospital Association (AHA), American Medical Association (AMA), and American Nurses Association (ANA) released a public service announcement (PSA) featuring their leaders urging the public to make sure they are up-to-date on their COVID-19 vaccines, including the updated…
The Food and Drug Administration last week removed the requirement for a positive COVID-19 test result to prescribe Paxlovid to certain adult and pediatric patients and Lagevrio to certain adults at risk of progressing to severe COVID-19.
The House last night voted 220-210 to pass legislation (H.R.382) that would immediately terminate the COVID-19 public health emergency, and 227-203 to pass legislation (H.R.497) that would eliminate the COVID-19 vaccine mandate for health care workers at facilities that participate in Medicare or…
The AHA is offering a new set of social messages and assets for February to encourage the public to get vaccinated and boosted against COVID-19.
A Food and Drug Administration advisory committee unanimously voted today to recommend harmonizing the composition of all primary series and booster doses administered in the U.S
In a study released today by the Centers for Disease Control and Prevention, a single bivalent COVID-19 vaccine booster provided additional protection against omicron XBB variants in adults who previously received two to four monovalent vaccine doses.
A Food and Drug Administration advisory committee is scheduled to vote Thursday on whether to simplify current COVID-19 vaccine use so that all primary series and booster doses administered in the U.S. would be bivalent.